How will the pharmaceutical companies, doctors and patients and legal cases be impacted by the recent SUPCO ruling in the Wyeth v. Levine case? Join Law.com bloggers and co-hosts, J. Craig Williams and Bob Ambrogi as they welcome Wyeth’s attorney, Bert W. Rein, founding partner of the law firm, Wiley Rein LLP, to discuss the wide-reaching impact this ruling will have for many years to come.
This week, the highly publicized case of Wyeth V. Levine came before the Supreme Court. The case involves Diana Levine, who lost her arm to gangrene due to an IV push with the drug, Phenergen. Law.com bloggers and co-hosts, J. Craig Williams and Bob Ambrogi, welcome Attorney Michael A. Ferrara, Jr. from the Ferrara Law firm and Attorney James Beck from the firm Dechert LLP and blogger for Drug and Device Law Blog, to discuss this big case. They will will look at Wyeth v. Levine, discuss the power of the FDA, federal pre-emption and what the upcoming ruling means for the future of Pharmaceutical companies and the FDA.